Fanqin Bu

592 citations
28 papers · 393 indexed · h-index 13
Topics
Extracellular vesicles in disease (10 papers)Cancer-related molecular mechanisms research (7 papers)Ferroptosis and cancer prognosis (5 papers)
Journals
Journal of the American Chemical SocietyAdvanced MaterialsSHILAP Revista de lepidopterología
Partner nations
ChinaSwitzerlandItaly

In The Last Decade

Fanqin Bu

27 papers receiving 392 citations

Peers

Fanqin Bu
Comparison fields: 5 of 78
  • Molecular Biology 252
  • Cancer Research 132
  • Oncology 95
  • Pulmonary and Respiratory Medicine 75
  • Biomedical Engineering 50
Replace Kaili Liao with:
Kaili Liao China
Yuanxi Huang China
Zhaoliang Liu China
Katherine D. Castle United States
Kun Mi China
Yunwei Han China
Naixin Liang China
Alba Rodríguez‐Martínez Spain
Teng Cheng China
Fengyan Han China
Fanqin Bu relative to Kaili Liao China Kaili Liao's profile →
Citations per field
00.5×1.5×
Kaili Liao · 1×
Citations per year

Countries citing papers authored by Fanqin Bu

Since Specialization
Citations

This map shows the geographic impact of Fanqin Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanqin Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanqin Bu more than expected).

Fields of papers citing papers by Fanqin Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanqin Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanqin Bu. The network helps show where Fanqin Bu may publish in the future.

Co-authorship network of co-authors of Fanqin Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Fanqin Bu. A scholar is included among the top collaborators of Fanqin Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanqin Bu. Fanqin Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 6
3 5
4 39
5 56
6 3
7 0
8 2
9 18
10 5
11 16
12 9
13 29
14 15
15 22
16 17
17 14
18 10
19 33
20 27

About Fanqin Bu

Fanqin Bu is a scholar working on Cancer Research, Applied Microbiology and Biotechnology and Oncology, having authored 28 papers that have together received 393 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (10 papers), Cancer-related molecular mechanisms research (7 papers) and Ferroptosis and cancer prognosis (5 papers). The work is most often cited by research in Cancer Research (132 citations), Molecular Biology (252 citations) and Oncology (95 citations). Fanqin Bu has collaborated with scholars based in China, Switzerland and Italy. Frequent co-authors include Xiaojian Zhu, Lin Kang, Li Min, Chen Luo, Jinfeng Zhu, Jun Huang, Shutao Wang, Jingxin Meng, Zhengming Zhu and Han Bao. Their work appears in journals such as Journal of the American Chemical Society, Advanced Materials and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026